Skip to main content
OpenTrials
Completed

NCT Number: NCT05265819

Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy

Effect of exergaming exercises and mediteranean diet on thyroid cancer patients following total thyroidectomy adult patients from both gender will be randomly assigned equally to exergaming exercises, Mediterranean diet groups using computer-generated block randomization.

Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed three times a week, for a total of 12 weeks Group C: Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.PREDIMED questionnaire is used To assess adherence to the Mediterranean diet Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nabil Mahmoud

Cairo, Giza Governorate, 11829, Egypt

About this study

Outcome measures

  • Flow cytometry analyzer for NKC (CD3- CD16+ CD56+).
  • Immunoassay analyzer for thyroid profile (TSH,T3,T4)
  • Quality of life questionnaire
  • Fatigue questionnaire
  • PREDIMED questionnaire to asses diet adherence. Outcome measures will be measured at baseline and after 3 months of the treatement intervention

A) assessment

  • Quality of life questionnaire questionnaire
  • .Fatigue questionnaire
  • Adherence to diet A validated 14-item questionnaire for the assessment of adherence to the Mediterranean Diet (PREDIMED) will be recorded for all the enrolled subjects
  • Biochemical Analysis. [B] Intervention
  • Exergaming The practice of exergaming was performed using the Xbox 360 Kinect console (Microsoft, Albuquerque, NM)
  • Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.

4 groups will be randomly assigned Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed three times a week, for a total of 12 weeks Group C: Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.PREDIMED questionnaire is used To assess adherence to the Mediterranean diet Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of thyroid papillary carcinoma as it is the most common type
  • Treatment with thyroid hormone medication after thyroidectomy
  • Lack of radioactive iodine treatment within the past 6 months
  • Blood hemoglobin level >10 g/dL.
  • Not taking drugs that could affect their immune function (e.g., immunosuppressants such as cyclosporin and steroids .
  • Lack of regular exercise
  • Age 18~45 years
  • Dose should be controlled at the first one year

-

Exclusion criteria

  • Abscess or inflammation suspected by preoperative tests 2) Patients with stage IV cancer and with limited understanding of assessment systems 3) History of head or neck malignancy . 4) Radiation therapy 5) Graves disease 6) Thyroiditis 7) Orthopaedic and rheumatic conditions of the neck . 8) The patient's inability to cooperate

-

Treatment and study plan

X-BOX kinetic360

Device
  • Exergaming The practice of exergaming was performed using the Xbox 360 Kinect console,The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed two to three times a week, for a total of 12 weeks.

Other names: thyroid hormone replacement therapy

Mediterranean diet

Dietary Supplement

Mediterranean diet participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.

Other names: thyroid hormone replacement therapy

thyroid hormone replacement therapy

Drug

thyroid hormone replacement therapy

Primary outcomes

  1. CD3-

    Time frame: 3 months

    CD3 (cluster of differentiation 3) is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell (CD8+ naive T cells) and T helper cells (CD4+ naive T cells). It is composed of four distinct chains.

    blood sample taken from the patients

  2. CD16+

    Time frame: 3 months

    CD16 is involved in antibody-dependent cell-mediated cytotoxicity and is expressed on large granular lymphocytes (LGLs) of both NK- and T-cell types.blood sample taken from the patients

  3. CD56+

    Time frame: 3 months

    CD56, is a member of the immunoglobulin superfamily engaged in both so-called homophilic and heterophilic interactions.blood sample taken from the patients

Secondary outcomes

  1. TSH(thyroid stimulating hormone)

    Time frame: 3 months

    TSH stands for thyroid stimulating hormone. A TSH test is a blood test that measures this hormone.

  2. T3 (triiodothyronine)

    Time frame: 3 months

    This test measures the level of triiodothyronine (T3) in your blood. T3 is one of two major hormones made by your thyroid

  3. T4 (Thyroxine)

    Time frame: 3 months

    Thyroxine, also known as T4, is a type of thyroid hormone. This test measures the level of T4 in your blood. Too much or too little T4 can indicate thyroid disease.

  4. Quality of life questionnaire

    Time frame: 3 months

    The World Health Organization (WHO) defined Quality of Life (QoL) as "an individual's perception of their position in life, in the context of the culture and value systems in which they live, and in relation to their goals, expectations, standards and concerns" . QoL is comprised of multiple aspects, including psychological health, physical well-being, social relationships, and environmental conditions [.

  5. Fatigue questionnaire

    Time frame: 3 months

    questionnaire is applied to the patients

Sponsors and collaborators

Lead sponsor

Nabil Mahmoud Ismail Abdel-Aal

Other

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Mar 4, 2022
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.